Psychopharmacology 1986-01-01

Bromocriptine and apomorphine stimulation of cortisol secretion in conscious dogs; evidence for a stimulatory site located outside the blood brain barrier.

M Goiny, K Uvnäs-Moberg, S Cekan

Index: Psychopharmacology 89(1) , 108-12, (1986)

Full Text: HTML

Abstract

IV injections of the dopamine receptor agonists bromocriptine (0.1 mg/kg) and apomorphine (0.05 mg/kg) induced rapid and long-lasting increases of cortisol levels as measured by RIA in peripheral venous plasma of conscious dogs. Pretreatment with dopamine receptor antagonists which do not readily penetrate the blood brain barrier (domperidone, halopemide, sulpiride) abolished the release responses induced by the dopamine agonists. These results suggest that the dopamine receptor agonists stimulate cortisol release at a site located outside the blood brain barrier. In addition, some dopamine receptor antagonists (haloperidol, chlorpromazine, milenperone) were shown to cause a rapid and long-lasting increase of cortisol levels.


Related Compounds

Related Articles:

CAY10593 inhibits the human P2X7 receptor independently of phospholipase D1 stimulation.

2013-12-01

[Purinergic Signal. 9(4) , 609-19, (2013)]

Halopemide, a new psychotropic agent. Cerebral distribution and receptor interactions.

1985-02-22

[Pharm. Weekbl. Sci. 7(1) , 1-9, (1985)]

Dynamic cation-exchange systems for the separation of drugs derived from butyrophenone and diphenylpiperidine by high-performance liquid chromatography and applied in the determination of halopemide in plasma.

[J. Chromatogr. A. 164(2) , 177-85, (1979)]

Endocrine effects of domperidone: a peripheral dopamine blocking agent.

1981-09-01

[Clin. Endocrinol. (Oxf.) 15(3) , 275-82, (1981)]

Effects of halopemide on potassium-induced release of radiolabeled neurotransmitters from rat cerebrocortical slices in vitro.

1980-09-01

[Arch. Int. Pharmacodyn. Ther. 247(1) , 43-58, (1980)]

More Articles...